Vertex Pharma scientist talks about the long road to developing non
WASHINGTON (AP) — For decades, patients seeking medication for pain have had two choices: over-the-counter drugs like aspirin or powerful prescription opioids like oxycodone.
Opioid prescriptions have plummeted over the last decade as doctors have become more attuned to the risks of addiction and misuse during the country’s ongoing drug epidemic.
Vertex Pharmaceuticals recently reported positive results for a non-opioid painkiller, one of several medications the Boston-based drugmaker has been developing for various forms of pain. Patients taking the drug after surgery experienced more pain relief than those getting a placebo, although the drug didn’t meet a secondary goal of outperforming treatment with an opioid.
The Associated Press spoke with Vertex’s chief scientist Dr. David Altshuler about the company’s research and development plans. The interview has been edited for length and clarity.
Related articles
Polish prosecutors open investigation after judge flees to autocratic Belarus
WARSAW, Poland (AP) — Polish prosecutors opened an investigation Monday after a Polish judge fled to2024-05-07Foreign envoys praise prosperous Xinjiang at conference
Grabbing machines transfer bulk cargo at the load-transfer yard of Horgos station in Horgos, northwe2024-05-07Qiaopi, Letters of Love from Overseas Chinese
Contact Us HomeNewsHighlightACWF NewsSocietyWom2024-05-07Xi Story: China's Youth Stand at Forefront of Innovation
Contact Us HomeNewsHighlightACWF NewsSocietyWom2024-05-07The yearly memorial march at the former death camp at Auschwitz overshadowed by the Israel
OSWIECIM, Poland (AP) — U.S. university presidents joined Holocaust survivors and thousands of Israe2024-05-07- Contact Us HomeNewsHighlightACWF NewsSocietyWom2024-05-07
atest comment